Sign In
Buy CAH
$201.74
+5.89 (+3.01%)
At Close: Jun 04, 2026
Three Stocks Rise, Watchlist Grows With Midterm Elections, Fed In Focus
05:32pm, Monday, 07'th Nov 2022
As Leaderboard stocks Enphase Energy, Wingstop and Cheniere Energy navigate Fed rate hikes, all eyes now turn to the midterm elections. The post Three Stocks Rise, Watchlist Grows With Midterm Electio
Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates
01:34pm, Friday, 04'th Nov 2022
Cardinal Health's (CAH) fiscal first-quarter results benefit from the solid performance of the Pharmaceutical segment.
Cardinal Health, Inc. (CAH) Q1 2023 Earnings Call Transcript
10:03am, Friday, 04'th Nov 2022
Cardinal Health, Inc. (NYSE:CAH ) Q1 2023 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Kevin Moran - Vice President of Investor Relations Jason Hollar - Chief Executive Of
Cardinal Health (CAH) Q1 Earnings and Revenues Surpass Estimates
09:48am, Friday, 04'th Nov 2022
Cardinal (CAH) delivered earnings and revenue surprises of 25% and 5.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cardinal Health Inches Higher On First-Quarter Beat, Maintained Guidance
09:03am, Friday, 04'th Nov 2022
Cardinal Health topped first-quarter estimates on Friday and maintained its adjusted EPS view, leading CAH stock to rise. The post Cardinal Health Inches Higher On First-Quarter Beat, Maintained Guida
Cardinal Health stock jumps toward 5-year high after big profit and revenue beats, affirmed outlook
07:17am, Friday, 04'th Nov 2022
Shares of Cardinal Health Inc. CAH, +0.83% jumped 4.4% toward a five-year high in premarket trading Friday, after the drug and laboratory products distributor reported fiscal first-quarter profit and
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
02:18pm, Monday, 31'st Oct 2022
Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have cont
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
08:00am, Saturday, 22'nd Oct 2022
S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market. The post S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Str
Check 5 Broker-Friendly Stocks for Returns Amid Market Chaos
07:32am, Friday, 21'st Oct 2022
Broker-favorite stocks like American Airlines (AAL), Delta (DAL), CVR Energy (CVI), Bunge Limited (BG) and Cardinal Health (CAH) should be on an investor's watch list.
Cardinal Health Clears Base, But Can It Maintain Uptrend?
01:21am, Thursday, 20'th Oct 2022
Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday.
The 3 Best Blue-Chip Stocks to Buy Now
01:52pm, Wednesday, 19'th Oct 2022
Investors are starting to clamor about whether we have seen the low for 2022 or, at the very least, whether the lows we reached last month will hold for the next several weeks. In any case, however in
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
02:18pm, Thursday, 13'th Oct 2022
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
Vertex Among 9 Stocks To Watch In Struggling Market
03:19pm, Monday, 03'rd Oct 2022
As the market indexes work through a downturn, Vertex is among nine stocks to watch showing relative strength. The post Vertex Among 9 Stocks To Watch In Struggling Market appeared first on Investor's
3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market
07:13pm, Tuesday, 27'th Sep 2022
We're in the midst of a bear market. That's something investors haven't seen in quite some time.
Seeking Income? Consider These 3 Dividend Aristocrats
06:28pm, Thursday, 15'th Sep 2022
During times of heightened volatility, an established income stream is undoubtedly a major positive, allowing investors to offset losses in other positions and reap those sweet dividend payouts.
